- Trials with a EudraCT protocol (78)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
78 result(s) found for: Visceral Pain.
Displaying page 1 of 4.
EudraCT Number: 2015-004596-72 | Sponsor Protocol Number: EXCALIBUR | Start Date*: 2016-04-06 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI" | |||||||||||||
Full Title: A phase II study evaluating the efficacy of enzalutamide and the role of ARv7 in metastatic castration resistant prostate cancer (mCRPC) patients with visceral disease | |||||||||||||
Medical condition: metastatic prostate cancer resistant to castration with visceral disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003441-16 | Sponsor Protocol Number: ML20570 | Start Date*: 2006-12-12 | |||||||||||
Sponsor Name:N.V. Roche S.A. | |||||||||||||
Full Title: OPEN LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS LOADING DOSE OF 3X 6MG IBANDRONIC ACID (BONDRONAT®) DURING 3 CONSECUTIVE DAYS IN PATIENTS WITH BREAST CANCER AND SKELETAL METASTA... | |||||||||||||
Medical condition: Metastasic bone pain in patients with breast cancer and bone metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002802-48 | Sponsor Protocol Number: ML 18107 | Start Date*: 2006-09-22 | |||||||||||
Sponsor Name:ROCHE | |||||||||||||
Full Title: Evaluation of efficacy and safety of i.v. and oral ibandronate in elderly patients with bone metastases from solid tumors. A randomised phase II study | |||||||||||||
Medical condition: Treatment of bone metastases in elderly patients with solid tumors | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000697-74 | Sponsor Protocol Number: ML20115 | Start Date*: 2006-08-07 |
Sponsor Name:The BONiFIN study group | ||
Full Title: A phase II, open label study to establish the safety and efficacy of intravenous loading dose of 3 x Bondronat 6 mg in 3 consecutive days in patients with breast cancer and skeletal metastases expe... | ||
Medical condition: Treatment of pain in breast cancer patients with bone metastases | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002223-42 | Sponsor Protocol Number: A4091061 | Start Date*: 2015-10-12 | |||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB (PF-04383119) IN SUBJECTS WITH CANCER ... | |||||||||||||
Medical condition: Metastatic Bone Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) CZ (Completed) GB (GB - no longer in EU/EEA) PL (Completed) ES (Completed) SK (Completed) HU (Completed) RO (Completed) FR (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001315-31 | Sponsor Protocol Number: GD032011 | Start Date*: 2011-09-21 |
Sponsor Name:University Hospitals Leuven | ||
Full Title: analgesia with continuous IV-infusion of lidocain during the perioperative period in patients undergoin laparoscopic sterilization. | ||
Medical condition: postoperative pain | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000812-27 | Sponsor Protocol Number: HEEL-2011-03 | Start Date*: 2012-07-19 | ||||||||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | ||||||||||||||||||
Full Title: The analgesic efficacy of Δ9-THC (Namisol®) in patients with persistent postsurgical abdominal pain: a randomized, double-blinded, placebo-controlled, parallel design’ | ||||||||||||||||||
Medical condition: Patients with persistent postsurgical abdominal pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-003648-22 | Sponsor Protocol Number: SAKK_2118 | Start Date*: 2020-02-26 | ||||||||||||||||
Sponsor Name:SAKK | ||||||||||||||||||
Full Title: Ribociclib-endocrine combination therapy versus chemotherapy as 1st line treatment in patients with visceral metastatic breast cancer. A multicenter, randomized phase III trial. | ||||||||||||||||||
Medical condition: Histologically or cytologically confirmed diagnosis of HR-positive, HER2-negative advanced stage breast cancer with measurable visceral metastases . | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: BE (Completed) AT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-003968-56 | Sponsor Protocol Number: CAAA617C12301 | Start Date*: 2021-04-06 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: PSMAddition : An International Prospective Open-label, Randomized, Phase III Study comparing 177Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patien... | |||||||||||||
Medical condition: PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Trial now transitioned) SE (Trial now transitioned) DE (Ongoing) DK (Trial now transitioned) NL (Trial now transitioned) PL (Trial now transitioned) BE (Trial now transitioned) AT (Trial now transitioned) CZ (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001855-12 | Sponsor Protocol Number: BO 18040 | Start Date*: 2004-02-16 |
Sponsor Name:F. Hoffmann-La Roche Ltd | ||
Full Title: Randomized, two arm, placebo controlled study to compare the efficacy of IV loading doses followed by maintenance treatment with IV ibandronic acid versus zoledronic acid in patients with skeletal ... | ||
Medical condition: Metastatic Bone Pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) GB (Completed) DE (Prematurely Ended) IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-001854-10 | Sponsor Protocol Number: BO18039 | Start Date*: 2005-02-16 |
Sponsor Name:F. Hoffmann-La Roche Ltd | ||
Full Title: Randomized, two arm, placebo controlled double dummy study to compare the efficacy of intravenous loading doses followed by maintenance treatment with oral ibandronic acid versus zoledronic acid in... | ||
Medical condition: Metastatic Bone Pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) GB (Completed) DE (Prematurely Ended) IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-003774-16 | Sponsor Protocol Number: EIFFEL | Start Date*: 2016-06-07 |
Sponsor Name:A.R.T.I.C. (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie ) | ||
Full Title: Phase I/II dose-finding, safety and efficacy study of radium-223 dichloride (XOFIGO®) in renal cell carcinoma patients with bone metastases | ||
Medical condition: Renal cell carcinoma patients with bone metastases, with or without visceral metastases. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001316-35 | Sponsor Protocol Number: KF6005/07 | Start Date*: 2012-12-20 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: Efficacy, safety, and tolerability of oral Cebranopadol versus morphine sulphate PR in subjects with chronic moderate to severe pain related to cancer. | |||||||||||||
Medical condition: The trial population, comprising patients with cancer pain requiring WHO Step III analgesics, will represent the typical population suffering from cancer-related pain. Patient having various types ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) DE (Prematurely Ended) HU (Completed) SE (Completed) ES (Completed) SK (Completed) PL (Completed) NL (Completed) AT (Completed) DK (Completed) BG (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000499-33 | Sponsor Protocol Number: 2006neuro06 | Start Date*: 2007-07-04 | |||||||||||
Sponsor Name:Queen Mary, University of London | |||||||||||||
Full Title: Effects of Pregabalin on acid-induced oesophageal pain hypersensitivity in male and female healthy adult volunteers, as investigated in a single centre, placebo-controlled, double-blind, randomised... | |||||||||||||
Medical condition: This study will test the effects of Pregabalin in a validated model of visceral pain hypersensitivity (VPH) in healthy volunteers. The volunteers must be free of medical conditions. VPH is thought ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002590-38 | Sponsor Protocol Number: 17777 | Start Date*: 2016-12-14 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled Phase III study of darolutamide (ODM-201) versus placebo in addition to standard androgen deprivation therapy and docetaxel in patients with metastati... | |||||||||||||
Medical condition: Metastatic hormone-sensitive prostate cancer (mHSPC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) SE (Completed) BE (Completed) ES (Completed) FI (Completed) DE (Completed) CZ (Completed) NL (Completed) PL (Completed) FR (Completed) BG (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001630-18 | Sponsor Protocol Number: CWL15001 | Start Date*: 2023-09-20 | |||||||||||
Sponsor Name:5med GmbH | |||||||||||||
Full Title: A randomized, parallel group, multi-center study of a fentanyl nasal spray compared with placebo nasal spray for postoperative pain management and prolonged open treatment over up to 120 hours post... | |||||||||||||
Medical condition: Management of pain following orthopedic surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) BG (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004867-19 | Sponsor Protocol Number: v1330032015 | Start Date*: 2015-02-24 |
Sponsor Name:Clinic for General Anesthesiology, Intensive Care and Pain Management | ||
Full Title: Perioperative fluid management in patients receiving major abdominal surgery – Effects of normal saline versus an acetate buffered balanced infusion solution on the necessity of catecholamines for ... | ||
Medical condition: hemodynamic stability of patients undergoing major surgery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-004342-42 | Sponsor Protocol Number: 201302 | Start Date*: 2014-03-26 | |||||||||||
Sponsor Name:Medisch Centrum Alkmaar | |||||||||||||
Full Title: The effect of fish oil supplements on hemorheological parameters and walking distance in patients with intermittent claudication | |||||||||||||
Medical condition: Patients suffering from intermittent claudication | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001950-18 | Sponsor Protocol Number: AST014 | Start Date*: 2007-07-23 |
Sponsor Name:Ocera Therapeutics, Inc. | ||
Full Title: A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF AST-120 IN PATIENTS WITH NON-CONSTIPATING IRRITABLE BOWEL SYNDROME | ||
Medical condition: Irritable bowel syndrome (IBS) is a chronic functional bowel disorder characterized by abdominal pain or discomfort and laterations in bowel habits. IBS is one of the most frequent conditions physi... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000730-19 | Sponsor Protocol Number: HEEL-2011-02 | Start Date*: 2012-08-23 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: The analgesic efficacy of Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain: a Randomized, Double-blinded, Placebo-controlled, Parallel Design | |||||||||||||
Medical condition: Chronic pancreatitis with persistant abdominal pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.